2.6
2023

Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria

D. Skander1, A. Allenova1, M. Maurer2, P. Kolkhir pavel.kolkhir@charite.de1,2
Vol. 53 (No. 2) 2021 March
Letter to the Editor
doi: 10.23822/EurAnnACI.1764-1489.153
Show more: Authors information and Publication history
Authors Information

1Division of Immune-mediated skin diseases, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation
2Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany

History


Published online: 22 February 2021
Accepted: 7 May 2020
Received:10 April 2020

KEY WORDS
Urticaria; omalizumab; treatment; chronic spontaneous urticaria; chronic inducible urticaria.
Full text PDF

Table of Content: Vol. 53 (No. 2) 2021 March

Original Article

Pediatric urticaria in the Emergency Department: epidemiological characteristics and predictive factors for its persistence in children

V. Talarico talaricovalentina@gmail.com1, G. L. Marseglia2, M. Lanari3, S. Esposito4, S. Masi5, M. De Filippo2, L. Gallelli6, A. Licari2, R. Lubrano7, S. Zampogna1, SIMEUP study group
doi: 10.23822/EurAnnACI.1764-1489.148
Download PDF

Letter to the Editor

Hymenoptera Venom Allergy: Re-Sting reactions

A. M. Mesquita mesquita.amb@gmail.com, L. Carneiro-Leão, L. Amaral, A. Coimbra
doi: 10.23822/EurAnnACI.1764-1489.156
Download PDF

Letter to the Editor

Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria

D. Skander1, A. Allenova1, M. Maurer2, P. Kolkhir pavel.kolkhir@charite.de1,2
doi: 10.23822/EurAnnACI.1764-1489.153
Download PDF

Case Report

Assessment of IgE- and cell-mediated immunity in pediatric patients with eosinophilic esophagitis

A. Yousefi1, S. Nasehi1, S. Arshi2, M. Nabavi2, M. H. Bemanian2, S. Shokri2, F. Seif3, M. Khoshmirsafa2, Y. Saeedi2, M. Sadeghian5, E. Talachian6, B. Rajabian4, F. Mahjoub7, M. Fallahpour fallahpour.m@iums.ac.ir2
doi: 10.23822/EurAnnACI.1764-1489.154
Download PDF

Original Article

Characteristics of patients with C1 esterase inhibitor deficiency: a single center study

E. Soyak Aytekin deniz.ayvaz@hacettepe.edu.tr 1, D. Çağdaş1,2, C. Tan2, İ. Tezcan1,2
doi: 10.23822/EurAnnACI.1764-1489.146
Download PDF

Original Article

Clinical trial to assess tolerability and subrogate efficacy effects of an abbreviated schedule with house dust mites mixture subcutaneous immunotherapy

I. Antépara1, A. Roger2, N. Bernedo3, R. Lleonart4, F. Rodríguez5, B. Madariaga6, J. A. Asturias6, L. Begoña6, A. Martínez6, A. Landeta6, M. C. Gómez-Fernández maricruz.gomez@roxall.es6
doi: 10.23822/EurAnnACI.1764-1489.140
Download PDF

Original Article

Correlations between disease activity, autoimmunity and biological parameters in patients with chronic spontaneous urticaria

L. de Montjoye laurence.demontjoye@uclouvain.be1,2, A-S. Darrigade1, A. Giménez-Arnau3, A. Herman1,2, L. Dumoutier4, M. Baeck1,2
doi: 10.23822/EurAnnACI.1764-1489.132
Download PDF

Review

Urticaria and coronavirus infection: a lesson from SARS-CoV-2 pandemic

A. Allegra1,2, R. Asero r.asero@libero.it3, A. Giovannetti4, S. Isola2,5, S. Gangemi5
doi: 10.23822/EurAnnACI.1764-1489.173
Download PDF

Contact

EDRA SPA

VIA G. SPADOLINI, 7

20141 MILANO – ITALY

PH. 0039 (0)2-88184.1

FAX 0039 (0)2-88184.301

WWW.EDRASPA.IT

FOLLOW US
European Annals of Allergy and Clinical Immunology ISSN 1764-1489 | © 2024